Abstract
Xeno-antiserum specific for antigenic components of bronchogenic carcinoma was raised in rabbits, by passively immunizing them to normal human lung antigens at the same time as immunization with a tumour extract from a squamous-cell carcinoma. Antiserum so raised contained minimal quantities of anti-normal antibody which could be removed by a single absorption with glutaral-dehyde-insolubilized normal lung extract. When tested by quantitative complement fixation with a panel of tumour extracts from surgical specimens, it was found that the antiserum gave positive complement fixation with all squamous-cell carcinoma extracts tested, and with some of the extracts from bronchogenic carcinomas of differing pathological types. The antiserum was essentially negative for pooled extracts from normal lung, liver and spleen but gave a weak positive reaction with an extract of pooled foetal lung tissue.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Kelly, B., Levy, J. Evidence for a common tumour-associated antigen in extracts of human bronchogenic carcinoma. Br J Cancer 35, 828–833 (1977). https://doi.org/10.1038/bjc.1977.125
Issue Date:
DOI: https://doi.org/10.1038/bjc.1977.125
This article is cited by
-
Specific cellular immunity detected by the in vitro monocyte spreading inhibition test in patients with bronchogenic carcinoma
Cancer Immunology Immunotherapy (1979)